Aquacool Air

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Currently, there are no detailed indications or usage specifications provided. Healthcare professionals are advised to refer to the latest clinical data and guidelines for appropriate prescribing information. There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product is intended for external use only. Healthcare professionals should ensure that the application site is clean and dry prior to administration. The recommended dosage and frequency of application should be determined based on the specific condition being treated and the patient's response to therapy.

It is essential to apply the product evenly to the affected area, avoiding contact with eyes, mucous membranes, and open wounds. The frequency of application may vary; therefore, healthcare professionals should monitor the patient's progress and adjust the dosing regimen as necessary to achieve optimal therapeutic outcomes.

Patients should be advised to wash their hands thoroughly after applying the product to prevent unintentional transfer to other areas of the body or to other individuals.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

Use of this product should be approached with caution, particularly in sensitive areas of the skin. Healthcare professionals are advised to conduct a patch test prior to liberal application to ensure patient safety and minimize the risk of adverse reactions. This precaution is essential to identify any potential sensitivity or allergic response that may occur upon application. Regular monitoring of the skin's reaction following the patch test is recommended to ensure continued safety during use.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this product. It is advised to use the product with caution on sensitive areas of the skin. Prior to liberal application, conducting a patch test is recommended to assess individual tolerance and minimize the risk of adverse effects.

In clinical practice, patients have reported various side effects, although specific frequency data is not provided. The importance of monitoring for any adverse reactions during use cannot be overstated, particularly in sensitive populations.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Aquacool Air (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area no more than 3 to 4 times daily. There are no specific dosage adjustments indicated for this age group. Care should be taken to adhere to the recommended application frequency to ensure safety and efficacy in this population.

Geriatric Use

Elderly patients may not have specific dosage adjustments, safety concerns, or special precautions outlined in the drug insert for AQUACOOL AIR (menthol spray). As there is no available information regarding the use of this product in geriatric populations, healthcare providers should exercise caution when prescribing to elderly patients. It is advisable to monitor these patients closely for any adverse effects or changes in response to treatment, given the general considerations for increased sensitivity in this age group.

Pregnancy

The available data regarding the use of AQUACOOL AIR menthol spray during pregnancy is limited. The drug insert does not provide specific information on the safety or risks associated with its use in pregnant patients. There are no contraindications noted for use during pregnancy, nor are there any statements regarding potential risks to the fetus. Additionally, no dosage modifications or special precautions for pregnant patients are mentioned. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the benefits against any potential risks when recommending this product during pregnancy.

Lactation

The safety of this product during lactation has not been established. There is a potential for excretion in breast milk; therefore, caution should be exercised when administering this product to nursing mothers.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols. Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective treatment and follow-up care.

Overall, while specific overdosage information is not available, vigilance and prompt intervention remain critical in managing potential overdose situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young children.

Storage and Handling

The product is supplied with an estimated shelf life of 2 years under normal room conditions. It should be stored at room temperature to maintain its efficacy. Prior to application, it is essential to shake the container well. When applying the product, the can should be held more than 20 cm away from the treatment area, and it should be applied using a sweeping motion. This product is intended for external use only.

Additional Clinical Information

The product is administered topically, with a recommended application frequency of no more than 3 to 4 times daily for adults and children aged 2 years and older. Clinicians should advise patients to keep the product out of reach of children and to perform a patch test prior to liberal application on the skin. Caution is advised when using the product on sensitive areas.

Drug Information (PDF)

This file contains official product information for Aquacool Air, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)